These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 854720)

  • 1. [Immune mechanisms in hepatitis B. New aspects and consequent practices].
    Frei PC
    Schweiz Med Wochenschr; 1977 Apr; 107(15):510-14. PubMed ID: 854720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immunity in viral hepatitis.
    Lee WM
    Am J Clin Pathol; 1976 May; 65(5 Suppl):866-9. PubMed ID: 85410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response and B hepatitis (author's transl)].
    Tittor W; Schwalbach G
    Leber Magen Darm; 1980 Aug; 10(4):179-85. PubMed ID: 7453469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects of hepatitis B virus infection.
    Edgington TS; Chisari FV
    Am J Med Sci; 1975; 270(2):212-27. PubMed ID: 799469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between the presence of specific circulating immune complexes and the leukocyte migration inhibition test in different clinical forms of hepatitis B].
    Krafft T; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1759-61. PubMed ID: 337469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathological mechanisms responsible for hepatic lesions caused by B virus].
    Vuitton D; Trepo C
    Pathol Biol (Paris); 1984 Mar; 32(3):190-8. PubMed ID: 6201804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
    Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
    Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of hepatitis B antigen positive and negative active chronic hepatitis.
    Williams R
    Dev Biol Stand; 1975; 30():341-9. PubMed ID: 1081961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
    Biglino A; Cariti G; Gioannini P
    Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
    Gupta RC
    Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course control and significance of circulating HBsAg-specific immune complexes in acute viral hepatitis B].
    Markus R; Baumgarten R; Fengler JD; Richter H; Apostoloff E
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):229-42. PubMed ID: 3803280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R
    Z Gesamte Inn Med; 1990 Oct; 45(20):623-5. PubMed ID: 2099582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different antibody responses against hepatitis B surface antigen among mouse strains transfected with mutant viral DNA.
    Hasegawa K; Joh R; Iizuka A; Naritomi T; Kanai N; Ogawa M; Torii N; Hayashi N
    J Gastroenterol; 2002; 37(12):1035-41. PubMed ID: 12522535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the immune response play a role in the pathogenesis of chronic liver disease?
    Mondelli MU; Manns M; Ferrari C
    Arch Pathol Lab Med; 1988 May; 112(5):489-97. PubMed ID: 3282484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.